Interstitial Lung Disease

Interstitial Lung Disease Treatment

Interstitial lung disease treatment

Interstitial Lung Disease Treatment Available at the Lung Institute

Treatment for interstitial lung disease is available at the Lung Institute, the only cellular therapy center in the world focusing exclusively on lung disease. We offer cellular therapy options that are designed to potentially address the progression of this disease and help improve quality of life for patients living with a severe pulmonary condition.

Cells have the remarkable power to aid in healing, as they can regenerate and transform themselves to function as different types of tissue. The Lung Institute offers cellular therapy: Blood-Derived Therapy, where cells are taken from the patient’s blood. The procedure is minimally invasive and are performed on an outpatient basis over the course of two days.

We use the following three-step process when performing natural cellular therapy:

  • Harvest – We remove a small sample of the patient’s blood.
  • Separate – We separate the cells from the remaining cells in the patient’s sample in our in-house lab.
  • Return – We intravenously return the concentrated cells into the patient’s bloodstream.

Although current treatments cannot reverse existing damage caused by the condition or cure lung disease, cellular therapy may slow the progression of lung disease. Many people coping with interstitial lung disease who have undergone cellular therapy at the Lung Institute have shown enhanced lung function and experienced improvement in their quality of life.

If you’re interested in learning more about the Lung Institute’s alternative interstitial lung disease treatment options, please call us today at (800) 729-3065. One of our devoted team members can answer any questions you may have and provide you with additional information. We look forward to helping you breathe easier.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.